ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,176Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 717

$1.26M Total Retail Price of All Prescriptions

Rank: 4 out of 717

562 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 562 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

2% of this provider’s 562 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

2% of this provider’s 10,982 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 33%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $88 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 779 613 1 2
DIVALPROEX SODIUM 407 253 2 103
LEVOTHYROXINE SODIUM 407 315 2 23
SIMVASTATIN 400 311 4 3
FUROSEMIDE 384 298 5 5
METFORMIN HCL 355 250 6 30
OMEPRAZOLE 350 243 7 28
METOPROLOL TARTRATE 326 259 8 8
NEXIUM 287 218 9 37
FAMOTIDINE 260 216 10 51
QUETIAPINE FUMARATE 252 187 11 125
DIOVAN 241 184 12 13
HALOPERIDOL 236 133 13 145
LISINOPRIL 219 154 14 9
BENZTROPINE MESYLATE 218 85 R 15 149
NAMENDA 215 191 16 78
DONEPEZIL HCL 199 189 17 57
MIRTAZAPINE 195 178 18 117
RISPERIDONE 193 127 19 115
ATORVASTATIN CALCIUM 175 105 20 4
GLIMEPIRIDE 174 124 21 59
GABAPENTIN 168 93 22 62
LEVETIRACETAM 167 105 23 147
OXYCODONE-ACETAMINOPHEN 160 67 S2 24 88
CRESTOR 159 91 25 11
HYDROCHLOROTHIAZIDE 149 129 26 17
METOPROLOL SUCCINATE 144 89 27 1
OLANZAPINE 141 97 28 178
CLOPIDOGREL 137 90 29 10
CLONIDINE HCL 132 84 30 48
SODIUM CHLORIDE 126 99 31 153
ALBUTEROL SULFATE 120 88 32 188
NOVOLOG 115 71 33 164
ZOLPIDEM TARTRATE 112 44 34 35
PLAVIX 112 86 34 12
NITROGLYCERIN PATCH 108 96 36 43
LACTULOSE 107 91 37 146
SEROQUEL 103 81 38 197
LOVAZA 102 54 39 33
CARVEDILOL 100 83 40 6
DIOVAN HCT 97 69 41 26
ENDOCET 97 42 S2 41 130
PROAIR HFA 94 40 43 97
IBUPROFEN 93 69 44 168
CLOZAPINE 88 16 45 203
CARBIDOPA-LEVODOPA 85 85 46 165
GEMFIBROZIL 84 22 47 205
TAMSULOSIN HCL 81 31 48 70
SERTRALINE HCL 81 50 48 81
JANUMET 81 57 48 150
ESCITALOPRAM OXALATE 80 49 51 106
OXCARBAZEPINE 79 47 52 209
CLOTRIMAZOLE-BETAMETHASONE 78 50 53 137
PREDNISONE 77 65 54 90
NAPROXEN 77 65 54 96
OXYCODONE HCL 75 32 S2 56 167
CILOSTAZOL 75 57 56 83
IPRATROPIUM BROMIDE 75 64 56 213
ADVAIR DISKUS 75 56 56 73
FLUVOXAMINE MALEATE 74 38 60 215
MUPIROCIN 74 61 60 184
DIVALPROEX SODIUM ER 73 20 62 216
ABILIFY 73 59 62 174
TRAZODONE HCL 72 36 64 172
RISPERDAL CONSTA 69 62 65 219
SANTYL 66 45 66 176
GLYBURIDE 65 46 R 67 139
AVELOX 64 41 68 226
JANUVIA 62 61 69 52
AZITHROMYCIN 60 35 70 55
HYDRALAZINE HCL 59 36 71 45
PHENYTOIN SODIUM EXTENDED 59 37 71 234
VALPROIC ACID 59 46 71 234
WARFARIN SODIUM 58 46 74 7
CELEBREX 55 37 75 94
SINGULAIR 55 29 75 95
ENALAPRIL MALEATE 55 39 75 24
PANTOPRAZOLE SODIUM 54 32 78 49
PEN NEEDLE 52 23 79 123
NOVOLOG FLEXPEN 51 44 80 126
BUDESONIDE 51 46 80 259
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.